bpc-157 human case reports and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded FDA panel backs compounded BPC-157,

-20C for long-term stability Post-reconstitution: Refrigerate at 2-8C, protect from light Reconstituted use window: 30 days for optimal research integrity Avoid: Repeated freeze-thaw cycles to preserve compound stability and structural integrity Quality Standards Mile High Compounds maintains a rigorous quality control framework across all research compounds

Some evidence suggests GHK-Cu may have anti-cancer properties, making it potentially more suitable for higher-risk individuals

Higher concentrations reduce injection volume but increase aggregation risk and decrease solution stability

Injectable for cosmetic claims is anecdotal